- Home
- CHGG vs BDTX Comparison
CHGG vs BDTX Comparison
Compare CHGG & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- BDTX
- Stock Information
- Founded
- CHGG 2005
- BDTX 2014
- Country
- CHGG United States
- BDTX United States
- Employees
- CHGG N/A
- BDTX N/A
- Industry
- CHGG Other Consumer Services
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHGG Real Estate
- BDTX Health Care
- Exchange
- CHGG Nasdaq
- BDTX Nasdaq
- Market Cap
- CHGG 149.2M
- BDTX 132.5M
- IPO Year
- CHGG 2013
- BDTX 2020
- Fundamental
- Price
- CHGG $1.36
- BDTX $2.94
- Analyst Decision
- CHGG Sell
- BDTX Strong Buy
- Analyst Count
- CHGG 7
- BDTX 6
- Target Price
- CHGG $1.70
- BDTX $14.83
- AVG Volume (30 Days)
- CHGG 3.7M
- BDTX 1.2M
- Earning Date
- CHGG 08-04-2025
- BDTX 08-05-2025
- Dividend Yield
- CHGG N/A
- BDTX N/A
- EPS Growth
- CHGG N/A
- BDTX N/A
- EPS
- CHGG N/A
- BDTX 0.09
- Revenue
- CHGG $564,611,000.00
- BDTX $70,000,000.00
- Revenue This Year
- CHGG N/A
- BDTX N/A
- Revenue Next Year
- CHGG N/A
- BDTX N/A
- P/E Ratio
- CHGG N/A
- BDTX $33.49
- Revenue Growth
- CHGG N/A
- BDTX N/A
- 52 Week Low
- CHGG $0.44
- BDTX $1.20
- 52 Week High
- CHGG $3.81
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- CHGG 53.54
- BDTX 70.75
- Support Level
- CHGG $1.32
- BDTX $2.43
- Resistance Level
- CHGG $1.49
- BDTX $2.72
- Average True Range (ATR)
- CHGG 0.11
- BDTX 0.18
- MACD
- CHGG -0.02
- BDTX 0.03
- Stochastic Oscillator
- CHGG 61.43
- BDTX 93.66
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.